Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;2(3):123-9.
doi: 10.4103/2279-042X.122386.

Pharmacist involvement in the patient care improves outcome in hypertension patients

Pranay Wal  1 , Ankita Wal  2 , Anil Bhandari  1 , Ummeshwar Pandey  3 , Awani K Rai  2
Affiliations

Pharmacist involvement in the patient care improves outcome in hypertension patients

Pranay Wal et al. J Res Pharm Pract. 2013 Jul.

Abstract

Objective: The main objective of this study was to assess the effects of pharmaceutical care interventions in patients with essential hypertension in Lakshmi Pat Singhania Institute of Cardiology, Kanpur, India.

Methods: The study was carried out from July 2010 to August 2011. Pharmaceutical care was provided for 54 patients (intervention group) which was comprised of the patient education, the prescription assistance and the life style modifications and motivation for health. Then the clinical outcome as well as health related quality of life (HRQOL) were compared with the control group (48 patients) in which the pharmaceutical care was not provided. Furthermore, the effect of pharmaceutical care intervention on HRQOL was assessed using Short Form-36 (SF-36), a general health related quality of life questionnaire used to evaluate the QOL of patients. Blood pressure (BP) measurements and QOL survey was performed at baseline and at the follow-up session.

Findings: The difference between blood pressure readings from the baseline to the second follow-up was significant for systolic [(P = 0.0001), 12.24 mmHg] and diastolic BP [(P = 0.001), 5.17 mmHg] in the intervention group. The questionnaire used to evaluate the QOL of patients also showed improvement in the mean score for intervention group.

Conclusion: Results from our study showed that applying pharmaceutical care to hypertensive patients can help in the control of these patients' blood pressure, and consequently lower the risk that hypertension poses in cardiovascular disease. Successful implementation of pharmaceutical care has the potential to increase patients' satisfaction with their pharmacists' activities and may increase patients' expectations that pharmacists will work on their behalf to assist them with their healthcare needs.

Keywords: Hypertension; pharmaceutical care; pharmacist; quality of life.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
CONSORT diagram of the study
Figure 2
Figure 2
Number of patients performing regular physical exercise in both groups, Grp: Group; BL: Baseline; FU: Follow-up
Figure 3a
Figure 3a
Mean systolic blood pressure in the intervention and control groups in the baseline and two follow-up visits, SBP: Systolic blood pressure
Figure 3b
Figure 3b
Mean diastolic blood pressure in the intervention and control groups in the baseline and two follow-up visits, DBP: Diastolic blood pressure
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wiedenmayer K, Summers RS, Mackie CA, Gaus AG, Everard M, Tromp D. Geneva: World Health Organization and International Pharmaceutical Federation; 2006. The definition of Pharmaceutical care in Developing pharmacy practice, A focus on patient care.
    1. Saseen JJ, Carter BL. Hypertension. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy. A pathophysiologic approach. 6th ed. New york: McGraw-Hill Companies; 2005. pp. 185–218.
    1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005;365:217–23. - PubMed
    1. Lawes CM, Vander SH, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. J Hypertens. 2006;24:423–30. - PubMed
    1. Brian BH. Therapy of hypertension. In: Laurance LB, John SL, Keith LP, editors. Goodman and Gilman's the pharmacological Basis of therapeutics. 11th ed. New York: McGraw Hill; 2005. p. 845.

LinkOut - more resources